Marketable Securities, Current in USD of ImageneBio, Inc. from Q1 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
ImageneBio, Inc. quarterly Marketable Securities, Current history and change rate from Q1 2022 to Q3 2025.
  • ImageneBio, Inc. Marketable Securities, Current for the quarter ending 30 Sep 2025 was $39.4M, a 57.5% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

ImageneBio, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $39.4M -$53.4M -57.5% 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $37.4M -$63.8M -63.1% 30 Jun 2025 10-Q 24 Jul 2025
Q1 2025 $77.3M -$27.2M -26% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $85M +$29.4M +52.9% 31 Dec 2024 10-Q 24 Jul 2025
Q3 2024 $92.8M +$17.2M +22.7% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $101M +$14.7M +17% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $104M -$3.99M -3.68% 31 Mar 2024 10-Q 13 May 2024
Q4 2023 $55.6M -$41.5M -42.7% 31 Dec 2023 10-K 06 Mar 2025
Q3 2023 $75.7M -$31.6M -29.5% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $86.4M -$57.9M -40.1% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $108M -$57M -34.5% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $97M 31 Dec 2022 10-K 12 Mar 2024
Q3 2022 $107M 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 $144M 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 $165M 31 Mar 2022 10-Q 12 May 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.